U.S.: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

U.S.: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

 

 

FDA
Press Announcements
January 7, 2022 – Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months

January 3, 2022 – Coronavirus (COVID-19) Update: FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine

 

 

Vaccines and Related Biological Products Advisory Committee– FDA
https://www.fda.gov/advisory-committees/blood-vaccines-and-other-biologics/vaccines-and-related-biological-products-advisory-committee
No meetings on calendar

 

 

::::::

 

White House [U.S.]
Briefing Room – Selected Major COVID Announcements
Press Briefing by White House COVID-⁠19 Response Team and Public Health Officials
January 05, 2022 Press Briefings

Remarks by President Biden Before Meeting on COVID-⁠19
January 04, 2022 Speeches and Remarks

 

 

U.S. Department of State
https://www.state.gov/coronavirus/releases/
Media Notes
Media Note
International Travel Challenges During COVID-19
December 30, 2021

Readout
Secretary Blinken’s Virtual Meeting with Foreign Ministers Regarding the Omicron Variant
December 21, 2021

Press Statement
Supporting Multilateral Responses to the COVID-19 Crisis
Antony J. Blinken December 21, 2021
The United States is providing an additional $580 million from the American Rescue Plan Act to support seven partners who are working tirelessly in our global fight against COVID-19. This funding includes:
$280 million for the World Health Organization (WHO), including $50 million for the Contingency Fund for Emergencies, to help contain the spread of COVID-19, particularly through surveillance and laboratory testing, and support the continuity of essential health services and systems, especially for individuals most at risk;
$170 million to the United Nations Children’s Fund (UNICEF) to expand its efforts to deliver COVID-19 vaccines around the world including to high-risk and vulnerable populations, provide critical COVID-19 commodities, such as Personal Protective Equipment and oxygen equipment, and support education needs in response to the COVID-19 pandemic;
$75 million to the Pan American Health Organization (PAHO) to provide technical cooperation to support implementation and monitoring of COVID-19 vaccinations in the Americas;
$20 million to the United Nations Development Program (UNDP) to help address the socioeconomic impact of COVID-19, including through programs for providing employment services and livelihood support;
$20 million for the United Nations Population Fund (UNFPA) to support its efforts to protect health workers and provide women with safe reproductive and maternal health care to mitigate higher rates of maternal and neonatal mortality and morbidity related to COVID-19;
$10 million to the Food and Agriculture Organization (FAO) to support its efforts to improve health surveillance, early warning, and risk assessment tools for zoonotic diseases; and
$5 million to UN Women to assist their efforts to support women and girls, in all their diversity, during the COVID-19 crisis, including a focus on programs to prevent and respond to gender-based violence.